Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1994
Improved outcome of high risk lymphoblastic leukemia (ALL) with laite high dose therapy. High dose versus conventional therapy for adult low risk T-ALL and Lymphoblastic lymphoma (LBL).
Epistemonikos ID: 7aa24941e5611318e0b9747d7094c4eafa3fccf4
First added on: May 04, 2024